Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 217.50
-25.45 (-10.48%)
At close: Mar 30, 2026
BOM:543916 Revenue
Hemant Surgical Industries had revenue of 646.20M INR in the half year ending September 30, 2025, with 11.02% growth. This brings the company's revenue in the last twelve months to 1.22B, up 15.15% year-over-year. In the fiscal year ending March 31, 2025, Hemant Surgical Industries had annual revenue of 1.07B with 0.97% growth.
Revenue (ttm)
1.22B
Revenue Growth
+15.15%
P/S Ratio
2.71
Revenue / Employee
11.88M
Employees
103
Market Cap
3.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.07B | 10.30M | 0.97% |
| Mar 31, 2024 | 1.06B | -35.41M | -3.24% |
| Mar 31, 2023 | 1.09B | 55.78M | 5.39% |
| Mar 31, 2022 | 1.04B | 438.05M | 73.30% |
| Mar 31, 2021 | 597.65M | 35.30M | 6.28% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Manaksia | 8.16B |
| Nikhil Adhesives | 5.29B |
| Megastar Foods | 5.08B |
| GEE Limited | 3.45B |
| Solarium Green Energy | 2.65B |
| Prime Fresh | 2.48B |
| Medicamen Biotech | 1.72B |
| RDB Rasayans | 1.17B |